4//SEC Filing
Strandberg Julia 4
Accession 0001062993-21-012400
CIK 0001835567other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:26 PM ET
Size
10.7 KB
Accession
0001062993-21-012400
Insider Transaction Report
Form 4
Strandberg Julia
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-03+625,775→ 625,775 totalExercise: $1.09Exp: 2029-09-26→ Common Stock (625,775 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+110,431→ 110,431 totalExercise: $1.29Exp: 2031-01-26→ Common Stock (110,431 underlying) - Award
Stock Option (Right to Buy)
2021-12-03+44,171→ 44,171 totalExercise: $1.09Exp: 2030-03-24→ Common Stock (44,171 underlying)
Footnotes (6)
- [F1]25% of the shares underlying the option vested or shall vest on July 22, 2020 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F2]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 425,000 shares of common stock of Private Pear for $1.60 per share.
- [F3]25% of the shares underlying the option vested or shall vest on March 24, 2021 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F4]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 30,000 shares of common stock of Private Pear for $1.60 per share.
- [F5]25% of the shares underlying the option vested or shall vest on January 26, 2022 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F6]Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 75,000 shares of common stock of Private Pear for $1.89 per share.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881152
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 5:26 PM ET
- Size
- 10.7 KB